Proteomics discovery of novel CSF biomarkers for disease progression in multiple sclerosis

被引：0
|
作者：
Teunissen, C. E.
Koel-Simmelink, M. J. A.
Piersma, S.
Pham, T.
Killestein, J.
Vrenken, H.
Berven, F.
Jimenez, C. R.
机构：
[1] VUmc Amsterdam, Amsterdam, Netherlands
[2] Univ Bergen, Bergen, Norway
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：504 / 504
页数：1
相关论文
共 50 条
  • [1] CSF Biomarkers of Disease Progression in Patients with Multiple Sclerosis
    Zanker, Shayna
    Harris, Violaine
    Sadiq, Saud
    [J]. NEUROLOGY, 2017, 88
  • [2] Novel CSF Biomarkers of Disease Progression of Amyotrophic Lateral Sclerosis
    Brettschneider, Johannes
    Steinacker, Petra
    Kaiser, Sarah
    Fang, Lubin
    Kuhle, Jens
    Petzold, Axel
    Tumani, Hayrettin
    Ludolph, Albert C.
    Otto, Markus
    [J]. NEUROLOGY, 2011, 76 (09) : A44 - A44
  • [3] Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics
    Shi, Yijun
    Ding, Yaowei
    Li, Guoge
    Wang, Lijuan
    Osman, Rasha Alsamani
    Sun, Jialu
    Qian, Lingye
    Zheng, Guanghui
    Zhang, Guojun
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Serum proteomics in multiple sclerosis disease progression
    Tremlett, Helen
    Dai, Darlene L. Y.
    Hollander, Zsuzsanna
    Kapanen, Anita
    Aziz, Tariq
    Wilson-McManus, Janet E.
    Tebbutt, Scott J.
    Borchers, Christoph H.
    Oger, Joel
    Freue, Gabriela V. Cohen
    [J]. JOURNAL OF PROTEOMICS, 2015, 118 : 2 - 11
  • [5] Relevance of biomarkers in disease progression in multiple sclerosis
    Kanodia, A. K.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (01) : 7 - 8
  • [6] Proteomics Discovery of Disease Biomarkers
    Ahram, Mamoun
    Petricoin, Emanuel F.
    [J]. BIOMARKER INSIGHTS, 2008, 3 : 325 - 333
  • [7] Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
    Ottervald, Jan
    Franzen, Bo
    Nilsson, Kerstin
    Andersson, Lars I.
    Khademi, Mohsen
    Eriksson, Bodil
    Kjellstrom, Sven
    Marko-Varga, Gyorgy
    Vegvari, Akos
    Harris, Robert A.
    Laurell, Thomas
    Miliotis, Tasso
    Matusevicius, Darius
    Salter, Hugh
    Ferm, Mats
    Olsson, Tomas
    [J]. JOURNAL OF PROTEOMICS, 2010, 73 (06) : 1117 - 1132
  • [8] Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine
    Del Boccio, Piero
    Rossi, Claudia
    di Ioia, Maria
    Cicalini, Ilaria
    Sacchetta, Paolo
    Pieragostino, Damiana
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2016, 10 (04) : 470 - 484
  • [9] Proteomics-Based Technologies in the Discovery of Biomarkers for Multiple Sclerosis in the Cerebrospinal Fluid
    Lourenco, A. S. T.
    Baldeiras, I.
    Graos, M.
    Duarte, C. B.
    [J]. CURRENT MOLECULAR MEDICINE, 2011, 11 (04) : 326 - 349
  • [10] CSF -amyloid as a putative biomarker of disease progression in multiple sclerosis
    Pietroboni, Anna M.
    di Cola, Francesca Schiano
    Scarioni, Marta
    Fenoglio, Chiara
    Spano, Barbara
    Arighi, Andrea
    Cioffi, Sara M. G.
    Oldoni, Emanuela
    De Riz, Milena A.
    Basilico, Paola
    Calvi, Alberto
    Fumagalli, Giorgio G.
    Triulzi, Fabio
    Galimberti, Daniela
    Bozzali, Marco
    Scarpini, Elio
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (08) : 1085 - 1091
12345